ATS Assemblies & Sections | Highlights: Interview with Dr. Jerry Zifodya and His Publication Clinical and Transcriptomic Risk Factors for Post-Tuberculosis Lung Disease in a Cohort of Kenyan Adults

If you're not redirected in a few seconds, click here

Welcome! You are invited to join a webinar: Bronchiectasis Management Reimagined: Key Updates from the 2025 ERS Guidelines. After registering, you will receive a confirmation email about joining the w...

ntm - University Health Partners of Hawaii

Welcome! You are invited to join a webinar: Bronchiectasis Management Reimagined: Key Updates from the 2025 ERS Guidelines. After registering, you will receive a confirmation email about joining the w...

Top ten research priorities for community-acquired pneumonia research: UK James Lind Alliance priority setting partnership

Time to Effective Therapy and Mortality in Community-Acquired Legionella Pneumonia: A Multicenter Retrospective Cohort Study

Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis

Comparing clinical assessments of pneumonia to bronchoalveolar lavage results in critically ill patients with suspected pneumonia

A 35-year-old man with progressive pulmonary dysfunction despite effective therapy of his cryptococcal pneumonia

Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adults

2027 Call for Nominations - Assembly Leadership Elections

Subphenotypes of pneumonia defined by pulmonary histopathological features

Macrophage membrane-coated nanoparticles control pathological inflammation and enhance survival in models of severe bacterial pneumonia

Spontaneous Auto-Bullectomy Following a Suspected Respiratory Infection

Clinical and cost effectiveness of pulmonary rehabilitation for people with post-tuberculosis lung disease in Kyrgyzstan: a single-blind randomized controlled trial

Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis

Inflammatory Phenotypes In Severe Pneumonia: Clinical Evidence To Mouse Models For Precision Therapeutics

Pneumococcal pneumonia in adults – re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020–2023 - Pneumonia

Validate User

Prognostic impact of rheumatoid arthritis on respiratory-related mortality in non-tuberculous mycobacterial pulmonary disease

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial

Converting donor dependence to domestic ownership: The realignment of tuberculosis financing for sustainability

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

Risk factors for postextubation pneumonia using diagnosis procedure combination and claims data in Japan - Scientific Reports

Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples | NEJM

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease | Antimicrobial Agents and Chemotherapy

The island biology of the host microbiome

Same-day versus rapid ART initiation in people with HIV and symptoms of tuberculosis (SaDAPT): a randomised, non-inferiority trial in Lesotho and Malawi

Association of linezolid interruption and rechallenge with clinical outcomes in patients with rifampicin-resistant tuberculosis in South Africa, 2018–22: an observational cohort study

Validate User

The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries: A modeling study